Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Global Indemnity Group
GBLI
$409M
| $310K | ﹤0.01% |
9,614
| – | – |
|
2977
Alerus Financial
ALRS
$839M
| $309K | ﹤0.01% |
13,800
+2,100
| +18% | +$39.7K |
|
|
ORLA
2978
DELISTED
Orla Mining
ORLA
| $309K | ﹤0.01% |
94,700
+67,100
| +243% | +$211K |
|
2979
SIFCO Industries
SIF
$126M
| $309K | ﹤0.01% |
68,034
+13,500
| +25% | +$56.8K |
|
2980
Enterprise Financial Services Corp
EFSC
$2.41B
| $304K | ﹤0.01% |
6,800
-14,950
| -69% | -$584K |
|
|
IGMS
2981
DELISTED
IGM Biosciences
IGMS
| $304K | ﹤0.01% |
36,600
-54,300
| -60% | -$315K |
|
2982
Karooooo
KARO
$1.93B
| $304K | ﹤0.01% |
12,501
+1,700
| +16% | +$40.8K |
|
|
FRGE
2983
DELISTED
Forge Global Holdings
FRGE
| $303K | ﹤0.01% |
+5,887
| New | +$250K |
|
|
MKFG
2984
DELISTED
Markforged Holding Corporation
MKFG
| $303K | ﹤0.01% |
37,010
-29,069
| -44% | -$254K |
|
|
AAT
2985
American Assets Trust
AAT
$1.4B
| $302K | ﹤0.01% |
13,400
-36,501
| -73% | -$723K |
|
2986
HF Foods Group
HFFG
$98.6M
| $302K | ﹤0.01% |
56,600
+4,100
| +8% | +$18.6K |
|
2987
MIND Technology
MIND
$42.8M
| $302K | ﹤0.01% |
45,840
-5,536
| -11% | -$28.2K |
|
2988
Vuzix
VUZI
$227M
| $299K | ﹤0.01% |
+143,400
| New | +$391K |
|
2989
First Mid Bancshares
FMBH
$1.39B
| $298K | ﹤0.01% |
8,600
-2,600
| -23% | -$78.5K |
|
2990
Finward Bancorp
FNWD
$196M
| $298K | ﹤0.01% |
+11,822
| New | +$252K |
|
2991
Zai Lab
ZLAB
$2.92B
| $298K | ﹤0.01% |
10,900
+600
| +6% | +$15.8K |
|
2992
Intellicheck
IDN
$56.9M
| $297K | ﹤0.01% |
156,100
+28,284
| +22% | +$53.8K |
|
2993
Ryman Hospitality Properties
RHP
$7.93B
| $297K | ﹤0.01% |
2,700
-76,541
| -97% | -$7.29M |
|
2994
GH Research
GHRS
$2.04B
| $295K | ﹤0.01% |
50,900
+6,500
| +15% | +$45.9K |
|
|
REE
2995
DELISTED
REE Automotive
REE
| $295K | ﹤0.01% |
57,477
-3,846
| -6% | -$16.2K |
|
2996
Yunhong Green CTI Ltd
YHGJ
$8.82M
| $295K | ﹤0.01% |
13,817
+398
| +3% | +$10.2K |
|
|
CBIO
2997
Crescent Biopharma
CBIO
$635M
| $294K | ﹤0.01% |
1,244
-767
| -38% | -$119K |
|
|
DMRA
2998
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.89B
| $293K | ﹤0.01% |
16,279
+8,075
| +98% | +$124K |
|
2999
Upland Software
UPLD
$16.7M
| $293K | ﹤0.01% |
6,930
+3,449
| +99% | +$149K |
|
3000
Viridian Therapeutics
VRDN
$2.5B
| $292K | ﹤0.01% |
13,400
-51,800
| -79% | -$818K |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.